Labetalol Hydrochloride Injection 5mg/1ml

Labetalol Hydrochloride Injection 5mg/1ml – LABLOCHEM INJ is a fast-acting antihypertensive injection formulated with Labetalol Hydrochloride 5 mg/1 ml, developed by Swisschem Healthcare. It belongs to a class of medications known as combined alpha and beta-adrenergic blockers, which help in effectively lowering blood pressure by reducing heart rate and relaxing blood vessels. This dual mechanism ensures controlled blood flow and reduces strain on the cardiovascular system. LABLOCHEM INJ is commonly used in hospital settings for the management of acute hypertension and hypertensive emergencies. Its injectable form allows rapid onset of action, making it a reliable choice for critical care situations under strict medical supervision.

Medical Uses

• LABLOCHEM INJ is used in the management of severe hypertension and hypertensive emergencies.
• It helps to control blood pressure during surgical procedures.
• The injection is beneficial in managing pregnancy-induced hypertension under medical supervision.
• It supports stabilization of blood pressure in critical care settings.
• It assists in preventing complications related to sudden blood pressure spikes.

Directions to Use

• LABLOCHEM INJ should be administered only by a qualified healthcare professional.
• It is given intravenously in a controlled clinical setting.
• Dosage is determined based on the patient’s condition and response.
• Continuous monitoring of blood pressure and heart rate is required during administration.
• Do not self-administer or use outside a medical facility.

Precautions

• Use this medication with caution in patients with asthma, heart block, or liver disorders.
• Inform your doctor about any existing cardiovascular or respiratory conditions.
• Avoid abrupt discontinuation without medical advice.
• Monitor vital signs closely during treatment.
• Use during pregnancy only if clearly indicated and prescribed by a doctor.

Storage

• Store in a cool, dry place away from direct sunlight.
• Keep the injection in its original packaging to maintain stability.
• Do not freeze or expose to excessive heat.
• Keep out of reach of children.
• Check expiry date before use and discard if expired.

Possible Side Effects

• Dizziness or fatigue may occur due to lowered blood pressure.
• Mild nausea or scalp tingling may be experienced.
• Slow heart rate (bradycardia) may occur in some patients.
• Allergic reactions or breathing difficulties may develop (Rare).
• Seek immediate medical attention if severe symptoms occur.

Frequently Asked Questions

Q: How does LABLOCHEM injection work to provide rapid control over blood pressure during emergencies?

A: The medication acts on both alpha and beta receptors, which enable it to re reduce heart rate and dilate blood vessels to lead to quick and effective blood pressure reduction.

Q: Why do healthcare professionals prefer Swisschem Healthcare’s LABLOCEHM INJ over other brands for critical care use?

A: LABLOCHEM INJ contains Labetalol Hydrochloride in its formulation, which makes it a high-quality sterile, and due to its consistent potency, it makes a reliable and preferred choice for hospital-based emergency treatments.

Q: Why is it necessary a continous monitoring during Labetalol Hydrochloride Injection administration?

A: Continuous monitoring, it ensures safe dosage adjustment, which helps to prevent complications like excessive blood pressure drop or slow heart rate.

Q: Can a patient with a pre-existing heart condition be prescribed Labetalol Hydrochloride Injection? Will it be safe for the patient?

A: It is strictly advised to use cautiously and only under medical supervision in case a patient has a pre-existing heart problem.

Q: What makes the LABLOCHEM injectable form more suitable and effective than oral anti-hypertensive medication?

A: The injectable form provides a faster onset of action than the oral medication, which makes it ideal for emergency cases.

Q: Do patients with respiratory disorders need to take precautions while being administered Labetalol Hydrochloride Injection?

A: Yes, if a patient has asthma or breathing issues, then they should be closely monitored due to the potential risk of bronchospasm.